Why the study?
Does adenovirus-mediated CTLA4Ig gene transfer prevent cardiac allorejection and prolong allograft survival in a rat model?
Population
Rat model of cardiac transplantation
Comparison
Adenovirus-mediated CTLA4Ig gene transfer into… vs Controls and systemic CTLA4Ig protein injection
Design
Preclinical
Follow-up
Up to 1 year
Authors
Loading...
Should not change clinical practice; leaves open translation of CTLA4Ig gene therapy to human cardiac allografts.
Does adenovirus-mediated CTLA4Ig gene transfer prevent cardiac allorejection and prolong allograft survival in a rat model?
Adenovirus-mediated CTLA4Ig gene transfer into the myocardium induces long-lasting local and systemic immunomodulation, leading to indefinite cardiac allograft survival and donor-specific tolerance in a rat model.
Guillot et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: